Literature DB >> 7744802

Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome.

I Jariel-Encontre1, M Pariat, F Martin, S Carillo, C Salvat, M Piechaczyk.   

Abstract

Degradation of rapidly turned over cellular proteins is commonly thought to be energy dependent, to require tagging of protein substrates by multi-ubiquitin chains, and to involve the 26 S proteasome, which is the major neutral proteolytic activity in both the cytosol and the nucleus. The c-Jun oncoprotein is very unstable in vivo. Using cell-free degradation assays, we show that ubiquitinylation, along with other types of tagging, is not an absolute prerequisite for ATP-dependent degradation of c-Jun by the 26 S proteasome. This indicates that a protein may bear intrinsic structural determinants allowing its selective recognition and breakdown by the 26 S proteasome. Moreover, taken together with observations by different groups, our data point to the notion of the existence of multiple degradation pathways operating on c-Jun.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744802     DOI: 10.1074/jbc.270.19.11623

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo?

Authors:  C Salvat; C Aquaviva; I Jariel-Encontre; P Ferrara; M Pariat; A M Steff; S Carillo; M Piechaczyk
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

2.  The sensitivity of c-Jun and c-Fos proteins to calpains depends on conformational determinants of the monomers and not on formation of dimers.

Authors:  M Pariat; C Salvat; M Bébien; F Brockly; E Altieri; S Carillo; I Jariel-Encontre; M Piechaczyk
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

3.  Regulation of the 26S proteasome by adenovirus E1A.

Authors:  A S Turnell; R J Grand; C Gorbea; X Zhang; W Wang; J S Mymryk; P H Gallimore
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

4.  Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

Review 5.  Degradation of connexins through the proteasomal, endolysosomal and phagolysosomal pathways.

Authors:  Vivian Su; Kimberly Cochrane; Alan F Lau
Journal:  J Membr Biol       Date:  2012-07-08       Impact factor: 1.843

6.  Proteasome pathway operates for the degradation of ornithine decarboxylase in intact cells.

Authors:  Y Murakami; N Tanahashi; K Tanaka; S Omura; S Hayashi
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

7.  Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers.

Authors:  Pietro Fratta; W King Engel; Janis McFerrin; Kelvin J A Davies; Sharon W Lin; Valerie Askanas
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 8.  Protein targeting to ATP-dependent proteases.

Authors:  Tomonao Inobe; Andreas Matouschek
Journal:  Curr Opin Struct Biol       Date:  2008-02-13       Impact factor: 6.809

9.  Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditions.

Authors:  Tilman Grune; Diana Botzen; Martina Engels; Peter Voss; Barbara Kaiser; Tobias Jung; Stefanie Grimm; Gennady Ermak; Kelvin J A Davies
Journal:  Arch Biochem Biophys       Date:  2010-05-15       Impact factor: 4.013

10.  CDNA cloning of p112, the largest regulatory subunit of the human 26s proteasome, and functional analysis of its yeast homologue, sen3p.

Authors:  K Yokota; S Kagawa; Y Shimizu; H Akioka; C Tsurumi; C Noda; M Fujimuro; H Yokosawa; T Fujiwara; E Takahashi; M Ohba; M Yamasaki; G N DeMartino; C A Slaughter; A Toh-e; K Tanaka
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.